endogenous tissue restoration

R&D

Paulo Neves, CMO of Xeltis, discusses transformative implants that enable the natural creation of living and long-lasting vessels.

News

Armed with new phase 3 data, Bayer is preparing to file a PET imaging agent that could accelerate the diagnosis of cardiac amyloidosis.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.